{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:42:12Z","timestamp":1774611732946,"version":"3.50.1"},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,5]]},"DOI":"10.18632\/oncotarget.7625","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T20:13:39Z","timestamp":1456258419000},"page":"18665-18677","source":"Crossref","is-referenced-by-count":30,"title":["High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status"],"prefix":"10.18632","volume":"7","author":[{"given":"Bhavna","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole V.","family":"Brown","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Swanson","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra C.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Current affiliation: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Old","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enver","family":"Ozer","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Schuller","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros N.","family":"Teknos","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Jemal","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Parkin","year":"2010","journal-title":"International Journal of Cancer"},{"key":"3","first-page":"1695","article-title":"Head and neck cancer","volume":"371","author":"Ferris","journal-title":"The Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Bourhis","year":"2009","journal-title":"Radiotherapy and Oncology"},{"key":"5","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2165\/11592540-000000000-00000","article-title":"Management of Recurrent Head and Neck Cancer","volume":"71","author":"Brockstein","year":"2011","journal-title":"Drugs"},{"key":"6","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.oraloncology.2015.07.002","article-title":"A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment","volume":"51","author":"Ringash","year":"2015","journal-title":"Oral Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.oraloncology.2013.02.013","article-title":"Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): Evidence from a prospective randomized study","volume":"49","author":"Agarwal","year":"2013","journal-title":"Oral Oncology"},{"key":"8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.oraloncology.2010.03.007","article-title":"Current trends and future perspectives in the surgical management of oral cancer","volume":"46","author":"Bhandari","year":"2010","journal-title":"Oral Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000055740","article-title":"Incidence and Sites of Distant Metastases from Head and Neck Cancer","volume":"63","author":"Mondin","year":"2001","journal-title":"ORL"},{"key":"10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1748-717X-6-70","article-title":"Long-term outcome and patterns of failure in patients with advanced head and neck cancer","volume":"6","author":"Lindel","year":"2011","journal-title":"Radiation Oncology"},{"key":"11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Viscidi","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Gillison","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"13","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.2007.12.7662","article-title":"EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer","volume":"26","author":"Kurnit","year":"2008","journal-title":"J Clin Oncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.oooo.2013.04.011","article-title":"Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics","volume":"116","author":"Teknos","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.2012.46.7746","article-title":"Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/hmg\/9.2.217","article-title":"Myoferlin, a candidate gene and potential modifier of muscular dystrophy","volume":"9","author":"McNally","year":"2000","journal-title":"Hum Mol Genet"},{"key":"17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1083\/jcb.91.1.26","article-title":"Sperm morphogenesis in wild-type and fertilization-defective mutants of Caenorhabditis elegans","volume":"91","author":"Nelson","year":"1981","journal-title":"The Journal of Cell Biology"},{"key":"18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1152\/physiolgenomics.00106.2009","article-title":"C. elegans dysferlin homolog fer-1 is expressed in muscle, and fer-1 mutations initiate altered gene expression of muscle enriched genes","volume":"40","author":"Lamitina","year":"2009","journal-title":"Physiological Genomics"},{"key":"19","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1242\/jcs.110.9.1073","article-title":"A nematode gene required for sperm vesicle fusion","volume":"110","author":"Ward","year":"1997","journal-title":"Journal of Cell Science"},{"key":"20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/1689","article-title":"A gene related to caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B","volume":"20","author":"Zatz","year":"1998","journal-title":"Nature Genetics"},{"key":"21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/geno.2000.6290","article-title":"The third human FER-1-like protein is highly similar to dysferlin","volume":"68","author":"Bashir","year":"2000","journal-title":"Genomics"},{"key":"22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jns.2007.04.016","article-title":"In silico functional and structural characterisation of ferlin proteins by mapping disease-causing mutations and evolutionary information onto three-dimensional models of their C2 domains","volume":"260","author":"Bashir","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"key":"23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/1682","article-title":"Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy","volume":"20","author":"Bejaoui","year":"1998","journal-title":"Nature Genetics"},{"key":"24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/7693","article-title":"A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness","volume":"21","author":"Petit","year":"1999","journal-title":"Nature Genetics"},{"key":"25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/345260a0","article-title":"Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C","volume":"345","author":"S\u00fcdhof","year":"1990","journal-title":"Nature"},{"key":"26","doi-asserted-by":"crossref","first-page":"22883","DOI":"10.1074\/jbc.M201858200","article-title":"Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains","volume":"277","author":"McNally","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"27","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1242\/dev.02155","article-title":"Normal myoblast fusion requires myoferlin","volume":"132","author":"McNally","year":"2005","journal-title":"Development"},{"key":"28","doi-asserted-by":"crossref","first-page":"20252","DOI":"10.1074\/jbc.M802306200","article-title":"The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion","volume":"283","author":"McNally","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1096\/fj.09-136309","article-title":"Myoferlin is required for insulin-like growth factor response and muscle growth","volume":"24","author":"McNally","year":"2010","journal-title":"FASEB Journal"},{"key":"30","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1242\/jcs.065375","article-title":"Myoferlin regulation by NFAT in muscle injury, regeneration and repair","volume":"123","author":"McNally","year":"2010","journal-title":"Journal of Cell Science"},{"key":"31","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1242\/dev.02155","article-title":"Normal myoblast fusion requires myoferlin","volume":"132","author":"McNally","year":"2005","journal-title":"Development"},{"key":"32","doi-asserted-by":"crossref","first-page":"30745","DOI":"10.1074\/jbc.M704798200","article-title":"Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function","volume":"282","author":"Sessa","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"33","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1158\/0008-5472.CAN-13-1142","article-title":"Myoferlin Is a Key Regulator of EGFR Activity in Breast Cancer","volume":"73","author":"Castronovo","year":"2013","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"e39766","DOI":"10.1371\/journal.pone.0039766","article-title":"Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion","volume":"7","author":"Kniss","year":"2012","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1021\/pr200527z","article-title":"Identification of Novel Accessible Proteins Bearing Diagnostic and Therapeutic Potential in Human Pancreatic Ductal Adenocarcinoma","volume":"10","author":"Castronovo","year":"2011","journal-title":"Journal of Proteome Research"},{"key":"36","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0959-8049(03)00419-2","article-title":"Gene expression profiles in human non-small and small-cell lung cancers","volume":"39","author":"Petersen","year":"2003","journal-title":"European Journal of Cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2164-6-37","article-title":"Gene expression signature of estrogen receptor \u03b1 status in breast cancer","volume":"6","author":"Aldaz","year":"2005","journal-title":"BMC Genomics"},{"key":"38","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/MLG.0b013e31813e5fbb","article-title":"Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus","volume":"117","author":"Mathews","year":"2007","journal-title":"Laryngoscope"},{"key":"39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review","volume":"14","author":"Franceschi","year":"2005","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"40","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States","volume":"29","author":"Anderson","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"41","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hed.21997","article-title":"Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status","volume":"34","author":"Chepeha","year":"2012","journal-title":"Head & Neck"},{"key":"42","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/PAS.0b013e3182299cde","article-title":"Human papillomavirus-related small cell carcinoma of the oropharynx","volume":"35","author":"Westra","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"43","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1541-7786.MCR-11-0271","article-title":"IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway","volume":"9","author":"Kumar","year":"2011","journal-title":"Mol Cancer Res"},{"key":"44","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/onc.2011.114","article-title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation","volume":"30","author":"Tang","year":"2011","journal-title":"Oncogene"},{"key":"45","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/onc.2013.209","article-title":"The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis","volume":"33","author":"Xu","year":"2014","journal-title":"Oncogene"},{"key":"46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1158\/1078-0432.CCR-13-3274","article-title":"Activation of IL6\/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4\/NANOG Expression","volume":"21","author":"Huang","year":"2015","journal-title":"Clinical Cancer Research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T23:58:52Z","timestamp":1654387132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":46,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,4,5]]}},"alternative-id":["7625","26919244"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7625","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}